Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection
NCT01278368 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2012-12-24
Summary
No comparative trial investigating the effect of preoperative chemotherapy for locally advanced pancreatic cancer on short-term postoperative outcome has been published so far. The aim of the present study is to assess the potential impact of preoperative chemotherapy on short-term postoperative outcome after pancreatic resection in a case-matched series of cancer patients.
Conditions
- Locally Advanced Pancreatic Adenocarcinoma
Interventions
- PROCEDURE
-
Pancreatic resection after preoperative chemotherapy
Pancreatic resection after preoperative chemotherapy
- PROCEDURE
-
Pancreatic resection
Pancreatic resection
Sponsors & Collaborators
-
Università Vita-Salute San Raffaele
lead OTHER
Principal Investigators
-
Marco Braga, MD · Università Vita-Salute San Raffaele
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer
NCT05888129 ·Status: COMPLETED
-
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
NCT07081360 ·Status: RECRUITING ·Phase: PHASE3
-
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
NCT05356039 ·Status: RECRUITING
-
Comparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic Cancer
NCT06978322 ·Status: COMPLETED
-
Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer
NCT01314027 ·Status: TERMINATED ·Phase: PHASE3
-
Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer
NCT06809374 ·Status: COMPLETED
-
NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer
NCT01521702 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas
NCT01783054 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study
NCT02782182 ·Status: TERMINATED ·Phase: PHASE1
-
Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer
NCT05634720 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Covid-19 Pandemic and Pancreatic Surgery in Italy
NCT04380766 ·Status: COMPLETED
-
Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer?
NCT06921252 ·Status: COMPLETED
-
Surgery for Locally Unresectable Pancreatic Cancer
NCT07241663 ·Status: RECRUITING
-
Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer
NCT01396681 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer
NCT07155629 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy
NCT03398291 ·Status: UNKNOWN ·Phase: PHASE3
-
Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
NCT06980792 ·Status: COMPLETED
-
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
NCT04340141 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
NCT01416662 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer
NCT03435536 ·Status: COMPLETED ·Phase: NA
-
Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer
NCT00960284 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer
NCT01150630 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas
NCT00003049 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
NCT02030860 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
NCT01240304 ·Status: TERMINATED ·Phase: PHASE2